METTL14 inhibited hematopoietic stem cell/progenitor cell differentiation and promotes leukemia by enhancing the m6A modification of MYB (HGNC:7545)/MYC (HGNC:7553) (Weng et al., 2018). Here, MYC is linked to leukemia.